{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:41:42Z","timestamp":1648939302465},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","issue":"2b","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:p>A s\u00edndrome de West (SW) \u00e9 uma epilepsia grave espec\u00edfica da inf\u00e2ncia, que se caracteriza pela tr\u00edade: espasmos em salvas, deteriora\u00e7\u00e3o ou atraso neuropsicomotor e hipsarritmia ao eletrencefalograma. OBJETIVO: Avaliar a efic\u00e1cia e seguran\u00e7a da vigabatrina (VGB) no tratamento da SW. M\u00c9TODO: Foram sujeitos do estudo todos os pacientes com diagn\u00f3stico estabelecido de SW, que freq\u00fcentam ou freq\u00fcentaram o Ambulat\u00f3rio de Epilepsia Infantil do Hospital das Cl\u00ednicas da UNICAMP, usam ou usaram VGB na tentativa de controlar as crises. Avaliamos sexo, idade, etiologia (sintom\u00e1tica ou criptog\u00eanica), doen\u00e7a(s) associada(s), idade do in\u00edcio dos espasmos, freq\u00fc\u00eancia das crises antes e ap\u00f3s o uso de VGB, achados de neuroimagem, EEG antes e depois do uso de VGB, medica\u00e7\u00f5es associadas, tempo para controle das crises, eletroretinograma, queixa visual ap\u00f3s uso de VGB, efeitos adversos e hist\u00f3ria familial de epilepsia. RESULTADOS: Foram avaliados 23 pacientes, sendo 16 do sexo masculino. A idade variou entre 1ano e 3 meses a 11 anos e 5meses (m\u00e9dia = 5anos e 3meses). Dezesseis (69,5%) pacientes apresentaram controle completo das crises, 5 (22%) tiveram controle parcial e em 2 (8,5%) pacientes os espasmos n\u00e3o foram controlados. Apenas uma paciente teve retinopatia gaba\u00e9rgica. Seis pacientes (26%) apresentaram eventos adversos - sonol\u00eancia, agressividade ou retinopatia. Os pacientes com o in\u00edcio da SW ap\u00f3s 6 meses de idade apresentaram melhor resposta \u00e0 VGB (p&lt;0,05). N\u00e3o houve diferen\u00e7a na resposta ao tratamento quanto ao tempo de introdu\u00e7\u00e3o da VGB ou \u00e0 etiologia (p&gt;0,05). Ap\u00f3s o tratamento com VGB, nenhum EEG apresentou hipsarritmia e 50% normalizaram. CONCLUS\u00c3O: Apesar do risco de retinopatia gaba\u00e9rgica, os resultados acima mostram que o uso da VGB no controle dos espasmos infantis se justifica em pacientes com SW.<\/jats:p>","DOI":"10.1590\/s0004-282x2005000300019","type":"journal-article","created":{"date-parts":[[2006,1,9]],"date-time":"2006-01-09T18:40:39Z","timestamp":1136832039000},"page":"469-473","source":"Crossref","is-referenced-by-count":5,"title":["Avalia\u00e7\u00e3o da efic\u00e1cia e tolerabilidade da vigabatrina na s\u00edndrome de West"],"prefix":"10.1590","volume":"63","author":[{"given":"Maria Helena P.","family":"Moraes","sequence":"first","affiliation":[{"name":"Universidade Estudual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Augusta","family":"Montenegro","sequence":"additional","affiliation":[{"name":"Universidade Estudual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata C.","family":"Franzon","sequence":"additional","affiliation":[{"name":"Universidade Estudual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 O.","family":"\u00c1vila","sequence":"additional","affiliation":[{"name":"Universidade Estudual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilisa M.","family":"Guerreiro","sequence":"additional","affiliation":[{"name":"Universidade Estudual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0387-7604(01)00264-9","article-title":"West syndrome: long-term prognosis and social aspects","volume":"23","author":"Appleton RE","year":"2001","journal-title":"Brain Dev","ISSN":"http:\/\/id.crossref.org\/issn\/0387-7604","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0887-8994(02)00400-9","article-title":"Vigabatrin for infantile spasms","volume":"27","author":"Mitchell WG","year":"2002","journal-title":"Pediatr Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0887-8994","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0387-7604(01)00230-3","article-title":"Newer antiepileptic drugs: advantages and disadvantages","volume":"23","author":"Wallace SJ","year":"2001","journal-title":"Brain & Dev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1212\/WNL.55.3.347","article-title":"Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss","volume":"55","author":"Harding GF","year":"2000","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/01.WNL.0000098938.80082.25","article-title":"Peripheral retinal dysfunction in patients taking vigabatrin","volume":"61","author":"McDonagh J","year":"2003","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0140-6736(90)90660-W","article-title":"Vigabatrin in infantile spasms","volume":"335","author":"Chiron C","year":"1990","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref7","first-page":"S52","article-title":"Therapeutic trial of vigabatrin in refractory infantile spasms","author":"Chiron C","year":"1991","journal-title":"J Child Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0883-0738","issn-type":"print"},{"key":"ref8","first-page":"988","article-title":"Vigabatrin in the treatment of epilepsy in patients with West syndrome and tuberous sclerosis","volume":"61","author":"Rotta NT","year":"2003","journal-title":"Arq Neuropsiquiatr","ISSN":"http:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0387-7604(01)00300-X","article-title":"Infantile spasms in tuberous sclerosis complex","volume":"23","author":"Curatolo P","year":"2001","journal-title":"Brain Dev","ISSN":"http:\/\/id.crossref.org\/issn\/0387-7604","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.57.8.1416","article-title":"Randomized trial of vigabatrin in patients with infantile spasms","volume":"57","author":"Elterman RD","year":"2001","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0887-8994(00)00218-6","article-title":"Steroids or vigabatrin in the treatment of infantile spasms?","volume":"23","author":"Riikonen RS","year":"2000","journal-title":"Pediatr Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0887-8994","issn-type":"print"},{"key":"ref12","first-page":"683","article-title":"West syndrome: clinical and electroencephalographic follow up of 70 patients and response to its treatment with adrenocorticotropic hormone, prednisone, vigabatrin, nitrazepam and valproate","volume":"58","author":"Antoniuk SA","year":"2000","journal-title":"Arq Neuropsiquiatr","ISSN":"http:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref13","article-title":"Vigabatrin as a first-choice drug in the treatment of West syndrome","author":"Fejerman N","journal-title":"J Child Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0883-0738","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1528-1157.1999.tb02049.x","article-title":"Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms","volume":"40","author":"Appleton RE","year":"1999","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1528-1157.1999.tb00802.x","article-title":"Treatment of infantile spasms of a population-based study with vigabatrin as the first drug for spasms","volume":"40","author":"Granstrom Ml","year":"1999","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/WNL.52.8.1691","article-title":"ACTH versus vigabatrin therapy in infantile spasms: a retrospective study","volume":"52","author":"Cossette P","year":"1999","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref17","first-page":"731","article-title":"Treatment of infantile spasms with vigabatrin as first-line therapy and in monoteraphy: apropos of 70 infants","volume":"5","author":"Villeneuve N","year":"1998","journal-title":"Arch Pediatr","ISSN":"http:\/\/id.crossref.org\/issn\/0096-6630","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2007-973549","article-title":"Vigabatrin as a first-line drug in West syndrome: clinical and electroencephalographic outcome","volume":"29","author":"Wohlrab G","year":"1998","journal-title":"Neuropediatrics","ISSN":"http:\/\/id.crossref.org\/issn\/0174-304X","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1528-1157.1997.tb00063.x","article-title":"Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study","volume":"38","author":"Vigevano F","year":"1997","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1212\/WNL.52.6.1201","article-title":"Outer retinal dysfunction in patients with vigabatrin","volume":"52","author":"Arndt CF","year":"1990","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.50.3.614","article-title":"Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings","volume":"50","author":"Krauss GL","year":"1998","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archopht.121.6.811","article-title":"Retinal function abnormalities in patients treated with vigabatrin","volume":"121","author":"Banin E","year":"2003","journal-title":"Arch Ophthalmol","ISSN":"http:\/\/id.crossref.org\/issn\/0003-9950","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1528-1157.2000.tb00117.x","article-title":"Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction","volume":"41","author":"Harding GF","year":"2000","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1528-1157.2001.28600.x","article-title":"Vigabatrin visual toxicity: evolution and dose dependence","volume":"42","author":"Malmgren K","year":"2001","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref25","first-page":"262","article-title":"Visual field loss associated with vigabatrin: quantification and relation to dosage","volume":"42","author":"Hardus P","year":"2001","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1014679804792","article-title":"Vigabatrin and retinal changes","volume":"104","author":"Jensen H","year":"2002","journal-title":"Doc Ophthalmol","ISSN":"http:\/\/id.crossref.org\/issn\/0012-4486","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s004150200041","article-title":"Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study","volume":"249","author":"Schmitz B","year":"2002","journal-title":"J Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0340-5354","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1528-1157.2003.55402.x","article-title":"Short-term nonhormonal and nonsteroid treatment in West syndrome","volume":"44","author":"Capovilla G","year":"2003","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/adc.85.6.469","article-title":"Vigabatrin associated retinal dysfunction in children with epilepsy","volume":"85","author":"Koul R","year":"2001","journal-title":"Arch Dis Child","ISSN":"http:\/\/id.crossref.org\/issn\/0003-9888","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00415-002-0789-y","article-title":"Is visual field constriction in patients treated with vigabatrin reversible?","volume":"249","author":"Schmidt T","year":"2002","journal-title":"J Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0340-5354","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s100720070096","article-title":"Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: is young age a favorable factor?","volume":"21","author":"Giordano L","year":"2000","journal-title":"Neurol Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0140-6736(99)02095-4","article-title":"Reversibility of vigabatrin-induced visual-field defect","volume":"354","author":"Versino M","year":"1999","journal-title":"The Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/seiz.2001.0544","article-title":"Reversed visual field constrictions in children after vigabatrin withdrawal: true retinal recovery or improved test performance only?","volume":"10","author":"Vanhatalo S","year":"2001","journal-title":"Seizure","ISSN":"http:\/\/id.crossref.org\/issn\/1059-1311","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v63n2b\/a19v632b.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T07:53:51Z","timestamp":1495698831000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2005000300019&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":33,"journal-issue":{"issue":"2b","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0004-282X2005000300019"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2005000300019","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}